-- / 20 shares
Concord Biotech IPO Details
Issue Date
--
Investment/lot
--
Price Range
₹741
Lot Size
20
IPO Size
₹1550.59 Cr
Concord Biotech IPO Listing Details
Listing On
18 Aug'23
Issue Price
--
Listed Price
₹ 900.05
Retail Gain/Listing Gain
▲21.46%
Schedule of Concord Biotech IPO
Start date
End date
Allotment of bids
Refund Initiation
Listing on exchange
18/08/2023
Company Background
Concord Biotech Ltd. is an Indian biopharmaceutical company, holding a prominent position among global developers and manufacturers (in terms of volume in 2022) of fermentation-based APIs. These Active Pharmaceutical Ingredients known as APIs, play a crucial role in preventing or curing diseases (Source: F&S Report).
The company also holds a market share of over 20% by volume in 2022, across fermentation-based API products, including mupirocin, sirolimus, tacrolimus, mycophenolate sodium and cyclosporine.
Concord Biotech supplies to over 70 countries including regulated markets, such as the United States, Europe, Japan, and India. In 2016, the company launched its formulation business in India as well as emerging markets, including Nepal, Mexico, Indonesia, Thailand, Ecuador, Kenya, Singapore and Paraguay, and have further expanded in the United States.
With that, let's take a look at the competitive strengths and risks factors for Concord Biotech Ltd:
Risk Factors
-
Delays in the supply and transport of raw materials may adversely impact the pricing and supply of end products, thus adversely affecting the business.
-
The company's reputation could be at risk if there are any manufacturing or quality control issues, potentially resulting in a decline in brand prominence.
-
Any slowdown or shutdown of its research and development operations can adversely affect the business.
Key Strategies
-
Continue to increase the API market share and further develop the product portfolio.
-
Increase the presence of existing formulations and expand into new formulations.
-
Grow the CDMO business.
Concord Biotech Ltd
Here are the key financials for Concord Biotech Limited.
How to apply for IPO through ASBA
Kotak Securities
•00m 58 s
How to apply for an IPO using UPI
Kotak Securities
•01m 19s
Concord Biotech IPO FAQs
When is Concord Biotech IPO listing date?
Concord Biotech will list on 2023-08-18.
What is the issue size of Concord Biotech IPO?
₹1550.59 Cr is the issue size of Concord Biotech IPO.
What is the price band of the Concord Biotech IPO?
The price band of Concord Biotech IPO is ₹741 to ₹0.
What is Concord Biotech Limited IPO?
The Concord Biotech Limited IPO has an issue size of Rs. 1,550.52 crores. The IPO opens for subscription on 4th August and ends on 8th August.
Who is the Registrar of Concord Biotech Limited IPO?
Link Intime India Private Limited is the registrar for this IPO.
Where can I read more about Concord Biotech Limited’s business?
You can read more about Concord Biotech Limited and its IPO from the company’s red herring prospectus (RHP) here.